Literature DB >> 15124930

In silico models for the prediction of dose-dependent human hepatotoxicity.

Ailan Cheng1, Steven L Dixon.   

Abstract

The liver is extremely vulnerable to the effects of xenobiotics due to its critical role in metabolism. Drug-induced hepatotoxicity may involve any number of different liver injuries, some of which lead to organ failure and, ultimately, patient death. Understandably, liver toxicity is one of the most important dose-limiting considerations in the drug development cycle, yet there remains a serious shortage of methods to predict hepatotoxicity from chemical structure. We discuss our latest findings in this area and present a new, fully general in silico model which is able to predict the occurrence of dose-dependent human hepatotoxicity with greater than 80% accuracy. Utilizing an ensemble recursive partitioning approach, the model classifies compounds as toxic or non-toxic and provides a confidence level to indicate which predictions are most likely to be correct. Only 2D structural information is required and predictions can be made quite rapidly, so this approach is entirely appropriate for data mining applications and for profiling large synthetic and/or virtual libraries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15124930     DOI: 10.1023/b:jcam.0000021834.50768.c6

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  14 in total

1.  Investigation of classification methods for the prediction of activity in diverse chemical libraries.

Authors:  S L Dixon; H O Villar
Journal:  J Comput Aided Mol Des       Date:  1999-09       Impact factor: 3.686

2.  One-dimensional molecular representations and similarity calculations: methodology and validation.

Authors:  S L Dixon; K M Merz
Journal:  J Med Chem       Date:  2001-11-08       Impact factor: 7.446

3.  Phase I trial of ilmofosine as a 24 hour infusion weekly.

Authors:  M von Mehren; B J Giantonio; C McAleer; R Schilder; J McPhillips; P J O'Dwyer
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

4.  Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies.

Authors:  D P Ryan; J G Supko; J P Eder; M V Seiden; G Demetri; T J Lynch; A J Fischman; J Davis; J Jimeno; J W Clark
Journal:  Clin Cancer Res       Date:  2001-02       Impact factor: 12.531

5.  Effects of tetrahydroaminoacridine on liver function in patients with Alzheimer's disease.

Authors:  J T O'Brien; S Eagger; R Levy
Journal:  Age Ageing       Date:  1991-03       Impact factor: 10.668

6.  Phase I clinical trial and pharmacokinetics of weekly ICRF-187 (NSC 169780) infusion in patients with solid tumors.

Authors:  C L Vogel; E Gorowski; E Davila; M Eisenberger; J Kosinski; R P Agarwal; N Savaraj
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

7.  Treatment of psoriasis with piritrexim, a lipid-soluble folate antagonist.

Authors:  C Guzzo; K Benik; G Lazarus; J Johnson; G Weinstein
Journal:  Arch Dermatol       Date:  1991-04

8.  Phase I trial and clinical pharmacology of elsamitrucin.

Authors:  M N Raber; R A Newman; B M Newman; R C Gaver; L P Schacter
Journal:  Cancer Res       Date:  1992-03-15       Impact factor: 12.701

9.  Toxic effects of tacrine on primary hepatocytes and liver epithelial cells in culture.

Authors:  D Lagadic-Gossmann; M Rissel; M A Le Bot; A Guillouzo
Journal:  Cell Biol Toxicol       Date:  1998-10       Impact factor: 6.691

10.  Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes.

Authors:  E J Gold; R H Mertelsmann; L M Itri; T Gee; Z Arlin; S Kempin; B Clarkson; M A Moore
Journal:  Cancer Treat Rep       Date:  1983-11
View more
  19 in total

1.  Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A.

Authors:  John H Cardellina; Virginia I Roxas-Duncan; Vicki Montgomery; Vanessa Eccard; Yvette Campbell; Xin Hu; Ilja Khavrutskii; Gregory J Tawa; Anders Wallqvist; James B Gloer; Nisarga L Phatak; Ulrich Höller; Ashish G Soman; Biren K Joshi; Sara M Hein; Donald T Wicklow; Leonard A Smith
Journal:  ACS Med Chem Lett       Date:  2012-04-02       Impact factor: 4.345

Review 2.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

3.  Machine Learning Models for Predicting Liver Toxicity.

Authors:  Jie Liu; Wenjing Guo; Sugunadevi Sakkiah; Zuowei Ji; Gokhan Yavas; Wen Zou; Minjun Chen; Weida Tong; Tucker A Patterson; Huixiao Hong
Journal:  Methods Mol Biol       Date:  2022

Review 4.  In Silico Models for Hepatotoxicity.

Authors:  Claire Ellison; Mark Hewitt; Katarzyna Przybylak
Journal:  Methods Mol Biol       Date:  2022

5.  Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Authors:  Denis Fourches; Julie C Barnes; Nicola C Day; Paul Bradley; Jane Z Reed; Alexander Tropsha
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739

6.  Active site fingerprinting and pharmacophore screening strategies for the identification of dual inhibitors of protein kinase C (ΡΚCβ) and poly (ADP-ribose) polymerase-1 (PARP-1).

Authors:  Navriti Chadha; Om Silakari
Journal:  Mol Divers       Date:  2016-05-23       Impact factor: 2.943

7.  Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution.

Authors:  Po-Yuan Chen; Ching-Tsan Tsai; Che-Yen Ou; Wei-Tse Hsu; Mien-De Jhuo; Chieh-Hsi Wu; Tzu-Ching Shih; Tzu-Hurng Cheng; Jing-Gung Chung
Journal:  Mol Med Rep       Date:  2012-01-17       Impact factor: 2.952

8.  A New Structure-Activity Relationship (SAR) Model for Predicting Drug-Induced Liver Injury, Based on Statistical and Expert-Based Structural Alerts.

Authors:  Fabiola Pizzo; Anna Lombardo; Alberto Manganaro; Emilio Benfenati
Journal:  Front Pharmacol       Date:  2016-11-22       Impact factor: 5.810

9.  Screening and characterisation of antimicrobial properties of semisynthetic betulin derivatives.

Authors:  Shafiul Haque; Dorota A Nawrot; Sami Alakurtti; Leo Ghemtio; Jari Yli-Kauhaluoma; Päivi Tammela
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

10.  Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches.

Authors:  Akbar Ali Khan Pathan; Bhavana Panthi; Zahid Khan; Purushotham Reddy Koppula; Mohammed Saud Alanazi; Narasimha Reddy Parine; Mukesh Chourasia
Journal:  Onco Targets Ther       Date:  2016-05-02       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.